quantitative assessment of wt1 expression by real time quantitative pcr in pediatric patients with acute myeloblastic leukemia

Authors

hossein ayatollahi department of hematology and blood bank, faculty of medicine, cancer molecular pathology research center, mashhad univerسازمان های دیگر: cancer molecular pathology research center

mohammad hadi sadeghian department of hematology and blood bank, faculty of medicine, cancer molecular pathology research center, mashhad univerسازمان اصلی تایید شده: دانشگاه علوم پزشکی مشهد (mashhad university of medical sciences)سازمان های دیگر: cancer molecular pathology research center

sepideh shakeri cancer molecular pathology research center, mashhad university of medical sciences, mashhad, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی مشهد (mashhad university of medical sciences)

seyyede fatemeh shams cancer molecular pathology research center, mashhad university of medical sciences, mashhad, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی مشهد (mashhad university of medical sciences)

abstract

increment. it is categorized based on genetic aberrations. some of these genetic disorders can determine minimal residual diseases (mrd) and prognosis of aml patients. wilms tumor (wt1) over expression is found in aml patients. the aim of this study was to determine the frequency of wt1 over expression in aml pediatric cases in north -east of iran. materials and methods: this retrospective study was done in mashhad, iran during 2016 in 100 pediatric aml cases. wt1 expression was evaluated by quantitative reverses transcription pcr (qrt-pcr) and cloning method. both wt1 and abl genes were cloned to create a standard curve and then copy number of wt1 gene in patients was evaluated. results: one hundred children under 15 with mean age of 6.50± 4.22 were evaluated in this study. there were no significant differences between age and sex and wt1 expression (p>0.05).  mean expression of cited gene was 200.52±210.62 copies of wt1/abl 104 in studied samples. wt1 gene over expression was observed in 82% of all patients. conclusion: wt1 assessment can be applied as a prognostic and diagnostic marker in aml patients under 15.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Quantitative Assessment of WT1 Expression by Real Time Quantitative PCR in Pediatric Patients with Acute Myeloblastic Leukemia

Background: Acute myeloid leukemia (AML) is one of myeloid malignancies which the risk increases with age increment. It is categorized based on genetic aberrations. Some of these genetic disorders can determine minimal residual diseases (MRD) and prognosis of AML patients. Wilms tumor (WT1) over expression is found in AML patients. The aim of this study was to determine the frequency of WT1 ove...

full text

quantitative assessment of wilms tumor 1 expression by real-time quantitative polymerase chain reaction in patients with acute myeloblastic leukemia

background: the wilms tumor 1 (wt1) gene is originally defined as a tumor suppressor gene and a transcription factor that overexpressed in leukemic cells. it is highly expressed in more than 80% of acute myeloid leukemia (aml) patients, both in bone marrow (bm) and in peripheral blood (pb), and it is used as a powerful and independent marker of minimal residual disease (mrd);we have determined ...

full text

Quantitative assessment of Wilms tumor 1 expression by real-time quantitative polymerase chain reaction in patients with acute myeloblastic leukemia

BACKGROUND The Wilms tumor 1 (WT1) gene is originally defined as a tumor suppressor gene and a transcription factor that overexpressed in leukemic cells. It is highly expressed in more than 80% of acute myeloid leukemia (AML) patients, both in bone marrow (BM) and in peripheral blood (PB), and it is used as a powerful and independent marker of minimal residual disease (MRD); we have determined ...

full text

Over-expression of Wilm’s Tumor Gene 1 (WT1) in Iranian Patients with Acute Myeloblastic Leukemia

Background: The Wilm’s tumor gene 1 (WT1) encodes a zinc finger transcription factor that is inactivated in a subset of Wilm’s tumors. It plays a crucial role in growth, proliferation and development of some embryonic and adult organs. WT1 is expressed as a tumor associated antigen (TAA) in various types of solid and hematopoietic malignancies and can be employed as a useful marker for targeted...

full text

Real-time quantitative PCR detection of WT1 and M-BCR-ABL expressions in chronic myeloid leukemia.

UNLABELLED The Philadelphia chromosome and the resulting BCR-ABL fusion gene represent the hallmark event in chronic myeloid leukemia (CML) and their discoveries radically changed the management of these patients. Currently Wilms tumor 1 gene (WT1) is intensively investigated as high WT1 expression levels have been demonstrated in case of multiple solid tumors and malignant hematological syndro...

full text

Expression Profile of Wnt Molecules in Leukemic Cells from Iranian Patients with Acute Myeloblastic Leukemia

Background: Wnt molecules play a key role in growth, proliferation and development of some embryonic and adult organs as well as hematopoietic stem cells. Wnt signaling pathways are aberrantly activated in many tumor types, including solid tumors and hematologic malignancies. Objective: To investigate the expression profile of a large number of Wnt genes in leukemic cells from Iranian patients ...

full text

My Resources

Save resource for easier access later


Journal title:
iranian journal of pediatric hematology and oncology

جلد ۷، شماره ۲، صفحات ۹۸-۱۰۴

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023